Because there is no widely available test to confirm the clinical diagnosis of Parkinson's disease (PD), other parkinsonian condifions are frequently misdiagnosed as PD. This poses problems for clinical trials and pafient care. Using FDG PET and spatial covariance mapping, we have idenfified patterns of brain metabolism that disfinguish PD, mulfiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the two most common atypical parkinsonian syndromes. Ufilizing a novel automated differenfial diagnosis algorithm, image-based classificafions can provide excellent diagnostic accuracy for idiopathic PD, even eariy in the disease course. Metabolic imaging with automated pattern analysis is thus a promising approach for accurate early diagnosis of PD vs. MSA or PSP. In this project, we will validate this approach in stricfiy defined patient populations, establish its false positive and false negative rates, and determine how early the metabolic abnormalifies are detectable by studying a populafion at risk for PD (individuals with REM behavior disorder, or RBD). Collaborations with Stanford University and the Udall Center at the University of Pennsylvania will broaden our patient base and enable us to test the feasibility of our approach across different movement disorder clinics and imaging centers.
In Specific Aim 1 we will test the sensitivity and specificity of our image-based automated classification in patients with unequivocal clinical diagnoses of PD, MSA, or PSP.
Specific Aim 2 will assess the diagnosfic accuracy of FDG PET in a real world context by testing our method in early parkinsonian subjects with an uncertain diagnosis.
Specific Aim 3 moves toward determining whether we can develop a biomarker to detect prodromal PD: we will determine whether there are presymptomatic changes in brain metabolism and dopaminergic funcfion in subjects with REM behavior disorder (RBD), a significant percentage of whom go on to develop PD. The development of a reliable technique for the early, objective, and accurate diagnosis of PD will improve clinical management, and will help to optimize the conduct of PD clinical research.

Public Health Relevance

This project will validate a widely available method (FDG PET) for use in the differential diagnosis of parkinsonism, and will assess this method's usefulness in a real world populafion of patients with early parkinsonism. In addifion, the study will ufilize PET imaging to examine abnormalities in brain funcfion in pafients at risk for developing Parkinson's disease (PD) who do not yet show signs of the disease (i.e. patients with REM Behavior Disorder). The development of a technology for the early, objective, and accurate diagnosis of PD will improve clinical management, and will help to opfimize the conduct of PD clinical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS071675-05
Application #
8742000
Study Section
Special Emphasis Panel (ZNS1-SRB-E)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
$541,758
Indirect Cost
$102,833
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Tripathi, Madhavi; Tang, Chris C; Feigin, Andrew et al. (2016) Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study. J Nucl Med 57:60-6
Vo, An; Sako, Wataru; Fujita, Koji et al. (2016) Parkinson's disease-related network topographies characterized with resting state functional MRI. Hum Brain Mapp :
Jourdain, Vincent A; Tang, Chris C; Holtbernd, Florian et al. (2016) Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. JCI Insight 1:e86615
Davis, Marie Y; Johnson, Catherine O; Leverenz, James B et al. (2016) Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. JAMA Neurol 73:1217-1224
Lerner, Renata P; Bimpisidis, Zisis; Agorastos, Stergiani et al. (2016) Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model. Neurobiol Dis 96:31-37
Leaver, Katherine; Poston, Kathleen L (2015) Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review. Neuropsychol Rev 25:411-23
Spetsieris, Phoebe G; Ko, Ji Hyun; Tang, Chris C et al. (2015) Metabolic resting-state brain networks in health and disease. Proc Natl Acad Sci U S A 112:2563-8
Ma, Yilong; Johnston, Tom H; Peng, Shichun et al. (2015) Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET. Mov Disord 30:1283-8
Müller-Oehring, Eva M; Sullivan, Edith V; Pfefferbaum, Adolf et al. (2015) Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease. Brain Imaging Behav 9:619-38
Ko, Ji Hyun; Lerner, Renata P; Eidelberg, David (2015) Effects of levodopa on regional cerebral metabolism and blood flow. Mov Disord 30:54-63

Showing the most recent 10 out of 38 publications